Financial Performance - The company's operating revenue for Q3 2023 was ¥75,710,873.85, a decrease of 25.33% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was -¥7,039,866.46, representing a decline of 150.17% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was -¥9,576,641.74, a decrease of 183.78% compared to the previous year[5]. - Total operating revenue for the first three quarters of 2023 was CNY 194,603,133.90, a decrease of 28.6% compared to CNY 272,399,886.56 in the same period of 2022[20]. - Net profit for the first three quarters of 2023 reached CNY 65,068,599.32, an increase of 93.5% from CNY 33,638,506.01 in the same period of 2022[22]. - Operating profit for the first three quarters of 2023 was CNY 76,548,515.19, up 88.0% from CNY 40,757,065.64 in the previous year[21]. Cash Flow - The cash flow from operating activities for the year-to-date period was -¥57,441,944.39, reflecting a decline of 121.12%[6]. - Cash flow from operating activities for the first three quarters of 2023 was CNY 159,108,855.83, a decrease from CNY 198,885,995.86 in the same period of 2022[24]. - The net cash flow from operating activities was -57,441,944.39, compared to 271,968,588.74 in the previous period, indicating a significant decline[25]. - Total cash inflow from investment activities was 725,772,545.78, while cash outflow was 829,215,464.61, resulting in a net cash flow of -103,442,918.83[25]. - Cash inflow from financing activities amounted to 219,942,000.00, with cash outflow of 53,310,264.45, leading to a net cash flow of 166,631,735.55[26]. - The company received 600,798,159.78 in cash from investment recoveries, reflecting strong investment management[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,575,678,920.06, an increase of 4.06% from the end of the previous year[6]. - The company's total assets amounted to CNY 1,575,678,920.06, an increase from CNY 1,514,252,528.46 in the previous period[21]. - The company's long-term equity investments increased to approximately 524.70 million RMB as of September 30, 2023, compared to 297.27 million RMB at the end of 2022[16]. - The company’s total liabilities amounted to approximately 363.54 million RMB as of September 30, 2023, compared to 320.75 million RMB at the end of 2022[16]. - The company's total liabilities as of the end of the reporting period were CNY 430,690,816.02, an increase from CNY 403,249,280.19 at the end of the previous period[21]. Shareholder Information - The equity attributable to shareholders at the end of the reporting period was ¥1,183,948,371.69, up 3.82% from the previous year[6]. - Total equity attributable to shareholders of the parent company was CNY 1,183,948,371.69, up from CNY 1,140,333,568.51 in the previous period[21]. - The total number of ordinary shareholders at the end of the reporting period was 30,860[10]. Foreign Exchange and Investments - The company reported a significant foreign exchange loss related to its investment in the WuXi AppTec project, impacting net profit[8]. - The company completed a total investment of 82.5 million USD in WuXi AppTec, with the completion of all contributions expected to reduce foreign exchange risk in Q4 2023[12]. - The company reported a total of 579.29 million RMB in current assets as of September 30, 2023, down from 665.03 million RMB at the end of 2022[15]. - The company reported a significant increase in investment income, reaching CNY 57,647,724.44 compared to CNY 17,596,896.31 in the previous year[21]. Government Subsidies and Incentives - The company received government subsidies amounting to ¥8,528,436.48 year-to-date, contributing to non-operating income[7]. - The company has implemented a stock incentive plan, with restricted stock and stock options granted on October 11 and 12, 2023, respectively[12]. Operational Expenses - The company paid 39,826,628.00 in cash to employees, indicating ongoing operational expenses[25]. - The cash received from other operating activities was 19,595,216.12, contributing to overall cash inflows[25]. - The company reported a total of 3,876,412.47 in tax refunds received, which positively impacted cash flow[25].
海利生物(603718) - 2023 Q3 - 季度财报